Alvotech

Price & Volume

Stats

52W Range	$7.35-$13.70
Market Cap	$2.5B
Shares Short	1M

Financials

Revenue (12 Mos)	$562.4M
Revenue Growth (YoY)	-12.8%
Gross Profit (12 Mos)	$303M
Diluted EPS	$0.23

News

Yahoo Finance • 5 days ago

European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency

Yahoo Finance • 5 days ago

Lyfjastofnun Evrópu tekur til umsagnar umsókn um markaðsleyfi fyrir fyrirhugaða hliðstæðu Alvotech við líftæknilyfið Xolair

Yahoo Finance • 18 days ago

Sector Update: Health Care Stocks Advance Tuesday Afternoon

Yahoo Finance • 19 days ago

European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®

About

CEO	Mr. Vilhelm Robert Wessman
Address	9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Full-Time Employees	1,012